NCT06175455

Brief Summary

Dynamic chest radiography (DCR) is a rapid and easily performed technique that captures real-time continuous images of the moving chest. COVID-19 has led to various complications and long-term effects, with dyspnea being a common symptom experienced by many patients. Studies conducted abroad have indicated that dyspnea following a new coronavirus infection can be attributed to diaphragm dysfunction. This study using DCR aims to describe diaphragm function in patients after coronavirus disease (COVID-19).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 10, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 14, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 19, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 10, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 10, 2025

Completed
Last Updated

December 26, 2023

Status Verified

December 1, 2023

Enrollment Period

4 months

First QC Date

December 14, 2023

Last Update Submit

December 19, 2023

Conditions

Keywords

coronavirusdiaphragm dysfunctiondynamic chest radiographydyspnea

Outcome Measures

Primary Outcomes (1)

  • diaphragm assessment

    observe the differences in dynamic chest X-ray measurements between patients with COVID-19 and normal people

    5 months

Secondary Outcomes (1)

  • Correlation between lung function and DCR

    5 months

Study Arms (2)

control

Healthy, age and sex matched controls

Device: dynamic chest radiography

Long Covid

patients who experienced persistent respiratory symptoms four weeks after contracting COVID-19

Device: dynamic chest radiography

Interventions

A recent technological advancement in this field is dynamic chest radiography (DCR), which is a low-dose imaging system capable of producing continuous moving images

Long Covidcontrol

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will compare a group of adults (over 18 years) in the community who experience breathlessness as a result of long COVID with a control group of healthy volunteers who are matched in terms of age and sex.

You may qualify if:

  • COVID-19 group:
  • Voluntarily sign the informed consent form;
  • Aged equal to or older than 18 years old, regardless of gender;
  • Inpatients with COVID-19 who mainly complain of dyspnea, dyspnea If it persists or develops and lasts for more than 4 weeks after acute COVID-19, it is related to long COVID-19; (confirmed infection with COVID-19 through nucleic acid monitoring or hospital laboratory data);
  • Lung function measurements have been completed during hospitalization due to diagnosis and treatment needs;
  • Be able to cooperate in completing the dynamic chest X-ray (complete the positioning of the dynamic chest X-ray for 20 seconds, and breathe calmly and forcefully during this period; be able to hold breath for at least 7 seconds).
  • Control group:
  • Voluntarily sign the informed consent form;
  • Aged equal to or older than 18 years old, regardless of gender;
  • People from the health examination center, and the age, gender are matched in the COVID-19 group and have no previous acute or chronic cardiopulmonary disease, no abnormalities in previous lung physical examinations and lung imaging examinations, and no history of infectious diseases in the past month;
  • Physical examination items are required People who are suitable for ordinary chest X-ray examination;
  • Be able to cooperate in completing dynamic chest X-ray (complete dynamic chest X-ray positioning for 20 seconds, during which period, breathe calmly and forcefully, and be able to hold breath for at least 7 seconds).

You may not qualify if:

  • COVID-19 group:
  • Not suitable to participate in this study;
  • Combined with serious life-threatening diseases, such as cardiovascular and cerebrovascular diseases, lung cancer, airway obstruction, etc.;
  • Combined with pneumothorax, pulmonary insufficiency, chronic disease, interstitial disease, lung surgery history or recent planned surgery;
  • Mental disorder and unable to cooperate with the operator;
  • Pregnant or lactating women;
  • Major radiation related to the research within 12 months before consent Exposure (participating in previous studies involving radiation exposure, the research dose is limited to 0.4mSv);
  • No evidence of having been infected with the new coronavirus;
  • Unable to cooperate in completing dynamic chest X-rays;
  • Unable to complete lung function measurements;
  • Control group:
  • Not suitable to participate in this study;
  • Patients with previous acute or chronic cardiopulmonary disease, previous lung physical examination, lung imaging examination abnormalities, within the past 1 month Have a history of infectious diseases;
  • Mentally abnormal and unable to cooperate with the operator;
  • Pregnant or lactating women;
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yudong

Guangzhou, Guangdong, China

RECRUITING

MeSH Terms

Conditions

Post-Acute COVID-19 SyndromeCoronavirus InfectionsDyspnea

Condition Hierarchy (Ancestors)

COVID-19Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesPost-Infectious DisordersChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsRespiration DisordersSigns and Symptoms, RespiratorySigns and Symptoms

Study Officials

  • Liu Laiyu, professor

    Nanfang Hospital, Southern Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Liu Laiyu, professor

CONTACT

Yu Dong, postgraduate

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 14, 2023

First Posted

December 19, 2023

Study Start

November 10, 2023

Primary Completion

March 10, 2024

Study Completion

March 10, 2025

Last Updated

December 26, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations